(Q51091869)

29 March 2018

title

A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. (English)

1 reference

29 March 2018

0 references

1 reference

Steinberg S

1

1 reference

29 March 2018

Annable L

series ordinal

2

1 reference

29 March 2018

Young SN

series ordinal

3

1 reference

29 March 2018

Liyanage N

series ordinal

4

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

29 March 2018

published in

Biological Psychiatry

1 reference

29 March 2018

volume

45

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

page(s)

313-320

1 reference

29 March 2018

Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

L-Tryptophan in the maintenance treatment of bipolar II manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

The eosinophilia-myalgia syndrome and tryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Premenstrual syndrome: documentation by a linear analog scale compared with two descriptive scales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Potentiation of lithium by tryptophan in a patient with bipolar illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Covariance analyses with heterogeneity of slopes in fixed models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Preventing depression with tryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

The Unpleasant Events Schedule: a scale for the measurement of aversive events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Clinical applications of visual analogue scales: a critical review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Acute tryptophan depletion aggravates premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Differences between males and females in rates of serotonin synthesis in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Serotonergic influences on the social behavior of vervet monkeys (Cercopithecus aethiops sabaeus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Tryptophan and neutral amino acids in premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Buspirone in treatment of premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Prospective assessment of menstrually related mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

State-dependent alterations in the perception of life events in menstrual-related mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Serotonergic function and late luteal phase dysphoric disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Fluvoxamine in the treatment of menstrually related mood disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Tryptophan treatment of aggressive psychiatric inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

Paroxetine as a treatment for premenstrual dysphoric disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900005-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(98)00005-5

1 reference

29 March 2018

1 reference

29 March 2018